Recursion Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Recursion Pharmaceuticals Inc
CIK #0001601830
EDGAR Form CIK 2011 - 2026
10-K [0001601830]
10-Q [0001601830]
3 [0001601830]
4 [0001601830]
8-K [0001601830]
D [0001601830]
SC 13D [0001601830]
SC 13G [0001601830]
Form 13D/13G Filer Form 13D/13G Subject Filed
State Street Corp Recursion Pharmaceuticals Inc [2026-05-12]
RA Capital Management LP Recursion Pharmaceuticals Inc [2024-07-08]
FMR LLC Recursion Pharmaceuticals Inc [2024-02-09]
Ark Investment Management LLC Recursion Pharmaceuticals Inc [2024-01-29]
State Street Corp Recursion Pharmaceuticals Inc [2024-01-24]
Kinnevik AB PUBL Recursion Pharmaceuticals Inc [2023-05-22]
Vanguard Group Inc Recursion Pharmaceuticals Inc [2023-02-09]
BlackRock Inc Recursion Pharmaceuticals Inc [2023-02-03]
Lux Capital Management LLC Recursion Pharmaceuticals Inc [2022-02-14]
Data Collective IV LP Recursion Pharmaceuticals Inc [2022-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
Dar Zavain
Recursion Pharmaceuticals Inc
Li Dean Y
Hershberg Robert
Michor Franziska
Sun Elaine D
Bumpus Namandje
Borgeson Blake
Taylor Ben R
Gibson Christopher
Khan Najat
Hallett David
Marriott Tina
Secora Michael
Mauro David J
Burrell Terry-Ann
Chavez R Martin
Virani Shafique
Bogue Zachary
Mamoura Diversified Global Holding PJSC
Mubadala Investment Co PJSC
Doyle Ramona
Lux Co-Invest Opportunities LP
Lux Co-Invest Partners LLC
Lux Ventures IV LP
Lux Venture Partners IV LLC
Hebert Peter
Wolfe Josh
MIC Capital Partners Public US IM LLC
DCVC Opportunity Fund II GP LLC
Data Collective IV LP
Data Collective IV GP LLC
DCVC V GP LLC
DCVC Opportunity Fund II LP
DCVC V LP
Ocko Matthew
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-03-23 Sell 40,000 $3.25 130,000
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-03-23 Conversion 40,000 $0.00
Recursion Pharmaceuticals Inc RXRX
Class B Common Stock · derivative
2026-03-23 Conversion 40,000 $0.00
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-03-17 Sell 7,956 $3.39 26,971
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-03-16 Tax withheld 7,075 $3.42 24,196
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-03-09 Sell 28,298 $3.35 94,798
Recursion Pharmaceuticals Inc RXRX
Class B Common Stock · derivative
2026-03-09 Conversion 20,000 $0.00
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-03-09 Gift 20,000 $0.00
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-03-09 Conversion 20,000 $0.00
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-03-03 Sell 170,000 $3.46 588,200
Recursion Pharmaceuticals Inc RXRX
Class B Common Stock · derivative
2026-02-19 Conversion 40,000 $0.00
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-02-19 Conversion 40,000 $0.00
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-02-19 Sell 40,000 $3.46 138,400
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-02-18 Sell 13,426 $3.08 41,352
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-02-17 Tax withheld 11,908 $3.49 41,559
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-02-17 Tax withheld 27,265 $3.49 95,155
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-02-17 Tax withheld 11,908 $3.49 41,559
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-02-17 Tax withheld 14,280 $3.49 49,837
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-02-06 Grant 1,673,546 $0.00
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
2026-02-06 Grant 24,254 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com